Decoy Receptor 2 as a Cell Cycle Arrest Biomarker for Predicting Renal Recovery Following Acute Kidney Injury
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70800 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Xiangling Yi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Daping Hospital, Army Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Acute Kidney Injury, Biomarkers, Cell Cycle Checkpoints, Kidney. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chongqing Science Foundation Project, National Natural Science Foundation of China, Chongqing Science and Health Joint Medical Research Project-Youth Project.
Abstract (Originalsprache)
Renal recovery following acute kidney injury (AKI) is a key determinant of long‐term prognosis, while non‐recovery significantly increases the risk of chronic kidney disease and progression to end‐stage renal disease. Although cell cycle arrest is implicated in renal non‐recovery and fibrosis, its association with decoy receptor 2 (DcR2) remains unclear. In this study, we evaluated 139 patients with biopsy‐confirmed AKI, defining renal non‐recovery as a ≥ 50% increase in baseline serum creatinine (Cr) or the initiation of dialysis. Patients were divided into recovery ( n = 79) and non‐recovery ( n = 60) groups. Urinary DcR2/creatinine (uDcR2/Cr) levels were significantly higher in non‐recovery cases, with an area under the curve of 0.733 and a diagnostic cut‐off of 378 ng/gCr. Elevated uDcR2/Cr predicted poor renal survival and was independently correlated with non‐recovery. In mouse models of ischemia–reperfusion‐induced AKI, increased urinary and tubular DcR2 levels were also associated with impaired recovery. Proteomics analysis revealed GSK3b enrichment in cell cycle pathways. Functional studies showed that DcR2 mediated cell cycle arrest through GSK3b/cyclin D1 signalling. In conclusion, DcR2 functions as a biomarker of cell cycle arrest and renal recovery, offering both diagnostic and mechanistic insights, and may serve as a potential therapeutic target in AKI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Daping Hospital, Army Medical University, Chongqing, China.
- The Key Laboratory of Precision Diagnosis and Treatment for Kidney Diseases of Chongqing, China.
- State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Chongqing, China.
ORCID-Profile: Jia Chen
Förderung
- Chongqing Science Foundation Project
- National Natural Science Foundation of China
- Chongqing Science and Health Joint Medical Research Project-Youth Project
- Chongqing Medical Youth Topnotch Talent Project
Zitieren
APA
Yi, X., Wang, L., Wang, X. Y., Fang, Y., Liu, J., Chen, K., He, Y. N., & Chen, J. (2025). Decoy Receptor 2 as a Cell Cycle Arrest Biomarker for Predicting Renal Recovery Following Acute Kidney Injury. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70800
Vancouver
Yi X, Wang L, Wang XY, Fang Y, Liu J, Chen K, et al. Decoy Receptor 2 as a Cell Cycle Arrest Biomarker for Predicting Renal Recovery Following Acute Kidney Injury. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70800
BibTeX
@article{Yi2025,
author = {Yi, Xiangling and Wang, Liming and Wang, Xiao-Yue and Fang, Yu and Liu, Jiarui and Chen, Kehong and He, Ya-Ni and Chen, Jia},
title = {Decoy Receptor 2 as a Cell Cycle Arrest Biomarker for Predicting Renal Recovery Following Acute Kidney Injury},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70800}
}
EUVIMED